产品名称 | ReVacc Scientific W95V9 | Human Anti-SARS-CoV-2 Spike RBD IgM Titer Serologic Assay Kit |
---|---|
目录号 | W95V9 |
别名 | Human Anti-SARS-CoV-2 Spike RBD IgM Titer Serologic Assay Kit |
外观 | 见COA |
分子量 | N/A |
CAS | N/A |
溶解度 | |
存储条件 | 见COA |
保存时间 | 见COA |
备注1 | |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
W95V9 | 96-well | 咨询 | 咨询 |
ReVacc Scientific W95V9 | Human Anti-SARS-CoV-2 Spike RBD IgM Titer Serologic Assay Kit
品名:Human Anti-SARS-CoV-2 Spike RBD IgM Titer Serologic Assay Kit
货号:W95V9
品牌:ReVacc Scientific
规格:96-well
产品描述
Organism:Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) caused the pandemic of COVID-19. The receptor-binding domain (RBD) subunit of the spike protein is to bind to its receptor on target cell surface (ACE2). A rapid and effective assay kit detecting the levels of anti-SARS-CoV-2 Spike RBD in human serum can facilitate research on antibodies produced in response to SARS-CoV-2 infection or vaccines.
This kit was tested to bind to monoclonal antibodies in IgM format (Cat. No. P80H48) or human sera, see figures.
This kit is developed for serologic test for human IgM titer of Anti-SARS-CoV-2 Spike RBD (Wuhan Strain) antibody in serum/plasma or purified human antibody (monoclonal & polyclonal) in vitro. It is for research use only. Antibodies of IgM and IgA class are a sign of an active infection (primary infection and reactivation) and disappear during convalescence. In some cases they can persist for several months.